XM does not provide services to residents of the United States of America.
N
N

NaturgyEnergy

News

Bernstein resumes Naturgy with 'market-perform' on limited upside potential

BUZZ-Bernstein resumes Naturgy with 'market-perform' on limited upside potential ** Bernstein resumes Naturgy NTGY.MC coverage with "market-perform" vs "underperform" when it discontinued coverage in April ** Sets PT at 24 euros ($26.73) ** Sees limited upside potential for Spanish utility co and doesn't expect the energy scenario to favour NTGY in
N

Auction Technology, Compass, D'Ieteren Group

EUROPE RESEARCH ROUNDUP-Auction Technology, Compass, D'Ieteren Group Sept 17 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Auction Technology, Compass Group and D'Ieteren Group on Tuesday. HIGHLIGHTS * Auction Technology Group Plc ATG.L : JP Morgan raises to overweight from neutral * Compass Group CPG.L : RBC cuts to sector perform from outperform * D'Ieteren Group SA IETB.BR : Jefferies cuts to hold from buy * Hermes HRMS.PA : Ex
B
B
B
C
D
E
E
E
E
H
H
L
N
R
R
R
S
S

Naturgy To Invest 265 Mln Euros In Two New Photovoltaic Plants In Australia

BRIEF-Naturgy To Invest 265 Mln Euros In Two New Photovoltaic Plants In Australia Sept 9 (Reuters) - Naturgy Energy Group SA NTGY.MC : TO INVEST 265 MILLION EUROS IN CONSTRUCTION OF TWO NEW PHOTOVOLTAIC PLANTS IN AUSTRALIA STARTS CONSTRUCTION OF TWO NEW FACILITIES WITH INSTALLED CAPACITY OF 360 MW AND SIGNED AGREEMENTS WITH TELSTRA FOR FUTURE SALE
N

Top of the Street: Sika, Haleon, Anglo American, VAT Group

BUZZ-Top of the Street: Sika, Haleon, Anglo American, VAT Group A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Stifel raises Swiss chemicals maker Sika SIKA.S to "buy" from "hold" after it increased its PT to CHF 270, which implies an upside of 11%, following the recent share price drop ** Goldman Sachs cuts consumer healthcare company Haleon HLN.L to "neutral" from "buy", as it sees limited catalysts to drive near term price performance, with Pfizer's
D
N
P
S
S
A

MS resumes Naturgy with 'equal weight' on fundamentals, flags low liquidity

BUZZ-MS resumes Naturgy with 'equal weight' on fundamentals, flags low liquidity ** Morgan Stanley resumes coverage of Spanish utility Naturgy NTGY.MC with "equal-weight" rating, citing improving fundamentals, but it flags low liquidity ** MS sees improving fundamentals for the company's breadth of business supporting steady EBITDA to 2030 from ele
N

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.